JACK CHRISTOPHER O'BRIEN

Allopathic & Osteopathic Physicians|Dermatology DALLAS, TX NPI 1639600596

General Payments — all program years on this page

$6,942.57

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 12
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $6,719.30 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $5,800.002
Food and Beverage $739.637
Travel and Lodging $179.671

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $6,492.337
Regeneron Healthcare Solutions, Inc. $109.011
UCB, Inc. $87.431
Gilead Sciences, Inc. $30.531

By program year

Program yearAmountRecords
2021 $100.181
2023 $123.091
2024 $6,719.3010

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087332209 Novartis Pharmaceuticals Corporation $4,000.00 05/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087341103 Novartis Pharmaceuticals Corporation $96.31 11/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087341107 Novartis Pharmaceuticals Corporation $165.91 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087341109 Novartis Pharmaceuticals Corporation $145.47 05/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087341111 Novartis Pharmaceuticals Corporation $179.67 05/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1087341115 Novartis Pharmaceuticals Corporation $104.97 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087341117 Novartis Pharmaceuticals Corporation $1,800.00 12/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114126514 Regeneron Healthcare Solutions, Inc. $109.01 07/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133736966 Gilead Sciences, Inc. $30.53 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143265586 UCB, Inc. $87.43 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.